Dewang PM - Search Results

1

Traceless solid-phase synthesis of carbolinones.

Chern MS, Shih YK, Dewang PM, Li WR. Chern MS, et al. Among authors: dewang pm. J Comb Chem. 2004 Nov-Dec;6(6):855-8. doi: 10.1021/cc049876i. J Comb Chem. 2004. PMID: 15530109 No abstract available.

2

Protein tyrosine phosphatases and their inhibitors.

Dewang PM, Hsu NM, Peng SZ, Li WR. Dewang PM, et al. Curr Med Chem. 2005;12(1):1-22. doi: 10.2174/0929867053363504. Curr Med Chem. 2005. PMID: 15638728 Review.

3

Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

Kim DK, Lee YI, Lee YW, Dewang PM, Sheen YY, Kim YW, Park HJ, Yoo J, Lee HS, Kim YK. Kim DK, et al. Among authors: dewang pm. Bioorg Med Chem. 2010 Jun 15;18(12):4459-67. doi: 10.1016/j.bmc.2010.04.071. Epub 2010 Apr 28. Bioorg Med Chem. 2010. PMID: 20472445

4

Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

Dewang PM, Kim DK. Dewang PM, et al. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4228-32. doi: 10.1016/j.bmcl.2010.05.032. Epub 2010 May 15. Bioorg Med Chem Lett. 2010. PMID: 20621731

5

Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma.

Naveen Sadhu M, Sivanandhan D, Gajendran C, Tantry S, Dewang P, Murugan K, Chickamunivenkatappa S, Zainuddin M, Nair S, Vaithilingam K, Rajagopal S. Naveen Sadhu M, et al. Bioorg Med Chem Lett. 2021 Feb 15;34:127763. doi: 10.1016/j.bmcl.2020.127763. Epub 2020 Dec 24. Bioorg Med Chem Lett. 2021. PMID: 33359604

6

Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.

Kim DK, Lim JH, Lee JA, Dewang PM. Kim DK, et al. Among authors: dewang pm. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4006-10. doi: 10.1016/j.bmcl.2008.06.007. Epub 2008 Jun 6. Bioorg Med Chem Lett. 2008. PMID: 18571921

7

Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

Kim DK, Jung SH, Lee HS, Dewang PM. Kim DK, et al. Among authors: dewang pm. Eur J Med Chem. 2009 Feb;44(2):568-76. doi: 10.1016/j.ejmech.2008.03.024. Epub 2008 Apr 4. Eur J Med Chem. 2009. PMID: 18467006

8

Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors.

Park MS, Park HJ, An YJ, Choi JH, Cha G, Lee HJ, Park SJ, Dewang PM, Kim DK. Park MS, et al. Among authors: dewang pm. J Enzyme Inhib Med Chem. 2020 Dec;35(1):702-712. doi: 10.1080/14756366.2020.1734799. J Enzyme Inhib Med Chem. 2020. PMID: 32164459 Free PMC article.

9

Validation of an LC-MS/MS method for simultaneous detection of four HDAC inhibitors - belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study.

Giri KK, Suresh PS, Saim SM, Zainuddin M, Bhamidipati RK, Dewang P, Hallur MS, Rajagopal S, Rajagopal S, Mullangi R. Giri KK, et al. Biomed Chromatogr. 2017 Jul;31(7). doi: 10.1002/bmc.3912. Epub 2017 Jan 22. Biomed Chromatogr. 2017. PMID: 27925271

10

Preclinical assessment of Orteronel(®), a CYP17A1 enzyme inhibitor in rats.

Zainuddin M, Vinod AB, Gurav SD, Police A, Kumar A, Mithra C, Dewang P, Kethiri RR, Mullangi R. Zainuddin M, et al. Eur J Drug Metab Pharmacokinet. 2016 Feb;41(1):1-7. doi: 10.1007/s13318-014-0229-2. Epub 2014 Oct 9. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25297456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page